MRI-based Identification and Classification of Major Intracranial Tumor Types by Using a 3D Convolutional Neural Network: A Retrospective Multi-institutional Analysis

Purpose: To develop an algorithm to classify postcontrast T1-weighted MRI scans by tumor classes (high-grade glioma, low-grade glioma [LGG], brain metastasis, meningioma, pituitary adenoma, and acoustic neuroma) and a healthy tissue (HLTH) class. Materials and Methods: In this retrospective study, preoperative postcontrast T1-weighted MR scans from four publicly available datasets-the Brain Tumor Image Segmentation dataset (n = 378), the LGG-1p19q dataset (n = 145), The Cancer Genome Atlas Glioblastoma Multiforme dataset (n = 141), and The Cancer Genome Atlas Low Grade Glioma dataset (n = 68)-and an internal clinical dataset (n = 1373) were used. In all, a total of 2105 images were split into a training dataset (n = 1396), an internal test set (n = 361), and an external test dataset (n = 348). A convolutional neural network was trained to classify the tumor type and to discriminate between images depicting HLTH and images depicting tumors. The performance of the model was evaluated by using cross-validation, internal testing, and external testing. Feature maps were plotted to visualize network attention. The accuracy, positive predictive value (PPV), negative predictive value, sensitivity, specificity, F1 score, area under the receiver operating characteristic curve (AUC), and area under the precision-recall curve (AUPRC) were calculated. Results: On the internal test dataset, across the seven different classes, the sensitivities, PPVs, AUCs, and AUPRCs ranged from 87% to 100%, 85% to 100%, 0.98 to 1.00, and 0.91 to 1.00, respectively. On the external data, they ranged from 91% to 97%, 73% to 99%, 0.97 to 0.98, and 0.9 to 1.0, respectively. Conclusion: The developed model was capable of classifying postcontrast T1-weighted MRI scans of different intracranial tumor types and discriminating images depicting pathologic conditions from images depicting HLTH. Supplemental material is available for this article. (C) RSNA, 2021.